secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2024-09-26T23:59:59+00:00
Accession:  0001104659-24-103160
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Armata VP Corporate Controller Richard Rychlik to depart on Sept 30, 2024
-------------------------------------------------------------------------

- Richard Rychlik, VP and Corporate Controller, will leave Armata effective September 30, 2024.
- Separation agreement terms are still being negotiated between Rychlik and the company.
- No successor named; role of Corporate Controller is currently unstaffed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465924103160/0001104659-24-103160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465924103160/tm2425034d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-103160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer